Trial Profile
Phase 1, Open-Label, Randomized, Safety and Pharmacokinetic Study of Two Final Formulations of ATX-101 (Sodium Deoxycholate Injection) Following Subcutaneous Injections in the Submental Fat
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Apr 2015
Price :
$35
*
At a glance
- Drugs Deoxycholic acid (Primary)
- Indications Subcutaneous fat disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Kythera Biopharmaceuticals
- 23 Apr 2015 New trial record